DUAVEE® Contraindications

(conjugated estrogens/bazedoxifene)

4 CONTRAINDICATIONS

DUAVEE is contraindicated in women with any of the following conditions:

Undiagnosed abnormal uterine bleeding
Known, suspected, or past history of breast cancer
Known or suspected estrogen-dependent neoplasia
Active deep venous thrombosis, pulmonary embolism, or history of these conditions
Active arterial thromboembolic disease (for example, stroke, myocardial infarction) or history of these conditions
Hypersensitivity (for example, anaphylaxis, angioedema) to estrogens, bazedoxifene, or any ingredients
Known hepatic impairment or disease
Known protein C, protein S, or antithrombin deficiency or other known thrombophilic disorders
Pregnancy, as DUAVEE may cause fetal harm [see pregnancy (8.1)].

Find DUAVEE® medical information:

Find DUAVEE® medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

DUAVEE® Quick Finder

Medication Guide

Health Professional Information

Contraindications

4 CONTRAINDICATIONS

DUAVEE is contraindicated in women with any of the following conditions:

Undiagnosed abnormal uterine bleeding
Known, suspected, or past history of breast cancer
Known or suspected estrogen-dependent neoplasia
Active deep venous thrombosis, pulmonary embolism, or history of these conditions
Active arterial thromboembolic disease (for example, stroke, myocardial infarction) or history of these conditions
Hypersensitivity (for example, anaphylaxis, angioedema) to estrogens, bazedoxifene, or any ingredients
Known hepatic impairment or disease
Known protein C, protein S, or antithrombin deficiency or other known thrombophilic disorders
Pregnancy, as DUAVEE may cause fetal harm [see pregnancy (8.1)].
Prescribing Information
Download Prescribing Information

Health Professional Information

Contraindications

4 CONTRAINDICATIONS

DUAVEE is contraindicated in women with any of the following conditions:

Undiagnosed abnormal uterine bleeding
Known, suspected, or past history of breast cancer
Known or suspected estrogen-dependent neoplasia
Active deep venous thrombosis, pulmonary embolism, or history of these conditions
Active arterial thromboembolic disease (for example, stroke, myocardial infarction) or history of these conditions
Hypersensitivity (for example, anaphylaxis, angioedema) to estrogens, bazedoxifene, or any ingredients
Known hepatic impairment or disease
Known protein C, protein S, or antithrombin deficiency or other known thrombophilic disorders
Pregnancy, as DUAVEE may cause fetal harm [see pregnancy (8.1)].

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.